Gulf International Bank (UK)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.02M Buy
17,152
+5,645
+49% +$1.86M 0.11% 178
2025
Q4
$4.03M Hold
11,507
0.13% 135
2025
Q3
$3.72M Sell
11,507
-236
-2% -$73.4K 0.12% 158
2025
Q2
$4.57M Sell
11,743
-1,467
-11% -$590K 0.16% 120
2025
Q1
$5.75M Sell
13,210
-4,750
-26% -$1.91M 0.2% 99
2024
Q4
$6.63M Sell
17,960
-204
-1% -$85.4K 0.17% 106
2024
Q3
$9.45M Sell
18,164
-801
-4% -$428K 0.24% 77
2024
Q2
$10.3M Sell
18,965
-635
-3% -$336K 0.26% 75
2024
Q1
$10.2M Buy
19,600
+123
+0.6% +$61.2K 0.26% 83
2023
Q4
$9.18M Sell
19,477
-2,263
-10% -$1.05M 0.26% 80
2023
Q3
$9.47M Sell
21,740
-2,245
-9% -$1.02M 0.27% 76
2023
Q2
$10.7M Sell
23,985
-7,467
-24% -$3.44M 0.26% 78
2023
Q1
$14.5M Sell
31,452
-8,939
-22% -$4.25M 0.3% 73
2022
Q4
$20.7M Buy
40,391
+20
+0% +$10.2K 0.36% 62
2022
Q3
$18.3M Hold
40,371
0.35% 58
2022
Q2
$19.6M Buy
40,371
+130
+0.3% +$64.3K 0.35% 61
2022
Q1
$19.8M Hold
40,241
0.3% 71
2021
Q4
$18.7M Sell
40,241
-8,612
-18% -$3.62M 0.26% 77
2021
Q3
$18.2M Sell
48,853
-563
-1% -$214K 0.23% 89
2021
Q2
$18.9M Sell
49,416
-206
-0.4% -$78.7K 0.24% 85
2021
Q1
$17.8M Sell
49,622
-5,431
-10% -$1.75M 0.24% 86
2020
Q4
$17.7M Sell
55,053
-4,225
-7% -$1.3M 0.23% 86
2020
Q3
$15.9M Sell
59,278
-407
-0.7% -$110K 0.22% 90
2020
Q2
$15.7M Buy
59,685
+430
+0.7% +$115K 0.24% 84
2020
Q1
$13.5M Hold
59,255
0.25% 90
2019
Q4
$17.9M Sell
59,255
-150
-0.3% -$41.3K 0.27% 75
2019
Q3
$14.3M Sell
59,405
-442
-0.7% -$121K 0.24% 89
2019
Q2
$16.9M Sell
59,847
-272
-0.5% -$74.3K 0.28% 71
2019
Q1
$17.3M Buy
60,119
+260
+0.4% +$75.2K 0.3% 72
2018
Q4
$15.7M Sell
59,859
-26,195
-30% -$7.2M 0.31% 71
2018
Q3
$23.6M Buy
86,054
+4,525
+6% +$1.17M 0.28% 75
2018
Q2
$19.4M Hold
81,529
0.24% 89
2018
Q1
$17.9M Sell
81,529
-965
-1% -$227K 0.23% 97
2017
Q4
$18.6M Sell
82,494
-500
-0.6% -$106K 0.24% 96
2017
Q3
$15.8M Buy
82,994
+700
+0.9% +$133K 0.21% 109
2017
Q2
$15.5M Buy
82,294
+120
+0.1% +$21.6K 0.22% 106
2017
Q1
$13.6M Buy
82,174
+2,000
+2% +$318K 0.2% 118
2016
Q4
$11.5M Buy
80,174
+1,200
+2% +$161K 0.18% 135
2016
Q3
$9.9M Buy
78,974
+600
+0.8% +$77.5K 0.16% 146
2016
Q2
$10.3M Hold
78,374
0.17% 132
2016
Q1
$10.9M Sell
78,374
-880
-1% -$118K 0.18% 123
2015
Q4
$11.1M Buy
79,254
+1,450
+2% +$200K 0.19% 122
2015
Q3
$10.9M Buy
77,804
+160
+0.2% +$24K 0.2% 114
2015
Q2
$12.7M Sell
77,644
-650
-0.8% -$104K 0.22% 109
2015
Q1
$12.1M Hold
78,294
0.22% 106
2014
Q4
$9.84M Sell
78,294
-500
-0.6% -$61.8K 0.17% 137
2014
Q3
$9.43M Sell
78,794
-120
-0.2% -$13.8K 0.17% 137
2014
Q2
$8.49M Sell
78,914
-4,746
-6% -$489K 0.16% 155
2014
Q1
$8.33M Hold
83,660
0.16% 149
2013
Q4
$7.73M Buy
+83,660
New +$7.43M 0.15% 154

Other funds holding ELV

Gulf International Bank (UK)'s ELV Position: Q1 2026 in Review

Gulf International Bank (UK) increased its Elevance Health (ELV) stake by 49% in Q1 2026, buying an estimated $1.86M and bringing the position to 17,152 shares worth $5.02M. The position accounts for 0.11% of the portfolio, ranked #178.

Gulf International Bank (UK) first reported a position in ELV in Q4 2013 and has held it in 50 quarters since. The position peaked at $23.6M in Q3 2018. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Gulf International Bank (UK) held 17,152 shares of Elevance Health worth $5.02M as of Q1 2026.
  • Gulf International Bank (UK) bought 5,645 Elevance Health shares in Q1 2026, an estimated $1.86M.
  • Elevance Health made up 0.11% of Gulf International Bank (UK)'s portfolio in Q1 2026, its #178 holding.
  • Gulf International Bank (UK) first reported a position in Elevance Health in Q4 2013 and has held it in 50 quarters since.
  • Gulf International Bank (UK)'s Elevance Health position peaked at $23.6M in Q3 2018.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Gulf International Bank (UK)'s 13F filing for Q1 2026, filed 11 May 2026.